Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

JW Pharmaceutical reports desfesoterodine derivatives

Oct. 10, 2016

Toray Industries prepares and tests agents for urinary incontinence

Oct. 6, 2016

FDA grants orphan drug designation to AbbVie's atrasentan

Oct. 5, 2016

Dimerix reports positive safety data for phase II trial of DMX-200

Oct. 5, 2016

twoXAR collaborates with Mount Sinai researchers in diabetic nephropathy

Oct. 5, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Regulus begins phase II trial of RG-012 in Alport syndrome

Sep. 22, 2016

Bayer and Evotec establish 5-year research partnership in kidney disease

Sep. 22, 2016

Promising phase II topline results for sparsentan in focal segmental glomerulosclerosis

Sep. 8, 2016

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...